Amygdala and Insula Retraining for Perimenopause

This trial explores a new mind-body program called Amygdala and Insula Retraining (AIR) to determine its effectiveness in reducing symptoms for individuals experiencing perimenopause. The program aims to improve issues such as sleep problems, hot flashes, fatigue, mood swings, and anxiety. Participants will either begin the AIR program immediately or after a short wait. Individuals who feel the effects of perimenopause, can read English, and have internet access may be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance quality of life during perimenopause.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team to understand any specific requirements.

Research has shown that Amygdala and Insula Retraining (AIR) is a safe treatment option. People using AIR for a year or more have reported improvements without harmful effects, suggesting the treatment is well-tolerated over time. Although specific negative effects are not detailed in the sources, the absence of reported problems in long-term users is reassuring. As a non-drug, mind-body approach, AIR often results in fewer side effects compared to medications, making it a potentially safer choice for managing perimenopausal symptoms.¹²³⁴⁵

Amygdala and Insula Retraining (AIR) is unique because it targets the brain's emotional centers, specifically the amygdala and insula, which are thought to play a role in the symptoms of perimenopause. Traditional treatments for perimenopause often focus on hormone replacement therapy (HRT) to manage symptoms, but AIR offers a non-hormonal approach. This method aims to retrain the brain's response to stress and emotional triggers, potentially providing relief without the side effects associated with hormone therapies. Researchers are excited about AIR because it represents a fresh approach that could help women who are seeking alternatives to hormonal treatments.

Research has shown that Amygdala and Insula Retraining (AIR) may help manage symptoms of chronic conditions such as chronic fatigue syndrome and fibromyalgia. Studies have found that AIR can enhance overall health and quality of life for individuals with these conditions. This method leverages neuroplasticity, the brain's ability to form new connections, to alter how the brain responds to stress and other triggers. Although specific results for perimenopause are not yet available, AIR's success in similar conditions suggests it could alleviate perimenopausal symptoms like sleep problems, tiredness, and mood swings. Early findings also indicate that AIR might improve the body's automatic functions, such as heart rate. Participants in this trial will either receive immediate access to the AIR program or continue with their usual treatment, with the option to access AIR after the primary outcome assessment.¹²³⁴⁵